Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
PharmaWiki - Olaparib
ShopUi
![Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969805122020856-ga1.jpg "Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect")
Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect
Supplementary appendix
Olaparib – Wikipedia
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
Olaparib - Wikipedia
PARP inhibitors: Synthetic lethality in the clinic | Science
Olaparib - Wikipedia
Olaparib - Wikipedia
olaparib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
A Wikipedia edit-a-thon for women in cancer research
Olaparib: Cos'è, A Cosa Serve, Quando si Assume
PARP inhibitor - Wikipedia
Tankyrase inhibitors as antitumor agents: a patent update (2013 – 2020)
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
olaparib | New Drug Approvals
Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian ca
Olaparib | AZD-2281 | CAS#763113-22-0 | MedKoo
